Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society.
第一作者:
Anna,Wong
第一单位:
University of Toronto Leslie Dan Faculty of Pharmacy, Toronto, Canada.
作者:
医学主题词
社会责任(Social Responsibility);人类(Humans);制药工业(Drug Industry);政府(Government);药费支出(Drug Costs);发展中国家(Developing Countries);卫生服务易得程度(Health Services Accessibility);私营部门(Private Sector);组织机构(Organizations)
DOI
10.1186/s12961-025-01421-w
PMID
41316254
发布时间
2026-01-15
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



